Urea Cream 41%

Urea


Canton Laboratories
Human Prescription Drug
NDC 69437-341
Urea Cream 41% also known as Urea is a human prescription drug labeled by 'Canton Laboratories'. National Drug Code (NDC) number for Urea Cream 41% is 69437-341. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Urea Cream 41% drug includes Urea - 410 mg/g . The currest status of Urea Cream 41% drug is Active.

Drug Information:

Drug NDC: 69437-341
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Urea Cream 41%
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Urea
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Canton Laboratories
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cream
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:UREA - 410 mg/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Jul, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 23 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Canton Laboratories
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1436933
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0369437341088
UPC stands for Universal Product Code.
UNII:8W8T17847W
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
69437-341-081 BOTTLE, PLASTIC in 1 CARTON (69437-341-08) / 227 g in 1 BOTTLE, PLASTIC01 Jul, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Urea cream 41% urea ceteareth-25 cetyl alcohol stearyl alcohol water sodium hydroxide xanthan gum ceteareth-6 mineral oil propylene glycol urea urea

Indications and Usage:

Indications and usage for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eshar. urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.

Warnings:

Warnings for topical use only. avoid contact with eyes, lips or mucous membranes.

Dosage and Administration:

Dosage and administration apply urea 41% to affected skin twice per day, or as directed by your physician. rub in until completely absorbed. apply to diseased or damaged nail(s) twice per day, or as directed by a physician. all prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. please note: this is not an orange book product and has not been subjected to fda therapeutic equivalency or other equivalency testing. no representation is made as to generic status or bioequivalency. each person recommending a prescription substitution using this product shall make such recommendations based on each person's professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical information provided herein.

Contraindications:

Contraindications known hypersensitivity to any of the listed ingredients.

Adverse Reactions:

Adverse reactions transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the medication.

Use in Pregnancy:

Pregnanacy: pregnancy category b. animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. because animal reproductive studies are not always predictive of human response, urea 41% should be given to a pregnant woman only if clearly needed.

Description:

Description urea 41% is a keratolytic emollient which is a gentle, yet potent, tissue softener for nails and/or skin. each gram of urea 41% contains 41% urea as an active ingredient, and the following inactive ingredients: ceteareth-6, ceteareth-25, cetyl alcohol, mineral oil, propylene glycol, purified water, sodium hydroxide, stearyl alcohol, xanthan gum. urea is a diamide of carbonic acid with the following chemical structure: image description

Clinical Pharmacology:

Clinical pharmacology urea gently dissolves the intracellular matrix which results in loosening of the horny layer of the skin and shedding of scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

Pharmacokinetics:

Pharmacokinetics the mechanism of action of topically applied urea is not yet known.

How Supplied:

How supplied urea 41% cream 8 oz.(227 g): ndc 69437-341-08 store at room temperature 15°c - 30°c (59°f - 86°f). protect from freezing. keep bottle tightly closed.

Package Label Principal Display Panel:

Marketed by: canton laboratories, llc 1015 nine north drive, suite 200 alpharetta, ga 30004 1-844-302-5227 label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.